GLEN ALLEN, Va., Feb. 12, 2014 /PRNewswire/ -- Star Scientific,
Inc., (NASDAQ: STSI) announced today that Theodore Jenkins has joined the Company as Vice
President, Corporate Strategy and Development. Mr. Jenkins will be
working directly with Dr. Michael
Mullan, Chairman and Chief Executive Officer, to enhance,
broaden, and clarify the Company's institutional investment and
corporate development efforts.
(Logo: http://photos.prnewswire.com/prnh/20130319/PH79245LOGO
)
Mr. Jenkins' experience encompasses an extensive 18-year Wall
Street career as an institutional capital markets professional,
working at top-tier, global and regional investment banks. He has a
proven history of generating significant client revenue and
communicating differentiated value with some of the largest
investment managers in the United States. He brings valuable
insight, aptitude, and knowledge from working with a wide spectrum
of biotech and pharmaceutical healthcare disciplines derived from
his close interaction with numerous companies in the sector and
with specialist healthcare finance professionals. As a
result, Mr. Jenkins has an abundance of relationships across the
institutional and corporate banking investment community.
Dr. Mullan commented, "I first met Ted a number of years ago and
have been impressed with his business, technical, and scientific
acumen, as it applies to the research and development strategy of
the Company. His tireless enthusiasm and experience will be an
invaluable asset for us."
Mr. Jenkins' background includes nine years as a US Navy Officer
serving as an aviator, flying F-14a tactical fighter aircraft and
finishing his tour as a professional development instructor
teaching midshipmen at the US Naval
Academy in Annapolis,
Maryland. He has a Master's of Science in Business from The
Johns Hopkins University, and an
undergraduate degree in International Studies from Washington College in Chestertown, Maryland.
Mr. Jenkins can be reached by email for institutional and
corporate inquiries at: tjenkins@rockcreekpharmaceuticals.com
Certain statements contained in this release constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements include,
but are not limited to statements identified by words such as
"believes," "expects," "anticipates," "estimates," "intends,"
"plans," "targets," "projects" and similar expressions. The
statements in this release are based upon the current beliefs and
expectations of our company's management and are subject to
significant risks and uncertainties. Actual results may differ from
those set forth in the forward-looking statements. Numerous factors
could cause or contribute to such differences, including, but not
limited to, results of clinical trials and/or other studies, the
challenges inherent in new product development initiatives,
including the continued development and market acceptance of our
nutraceutical dietary supplements products, the effect of any
competitive products, our ability to license and protect our
intellectual property, our ability to raise additional capital in
the future that is necessary to maintain our business, changes in
government policy and/or regulation, potential litigation by or
against us, any governmental review of our products or practices
and the outcome of the ongoing investigations as well as other
risks discussed from time to time in our filings with the
Securities and Exchange Commission, including, without limitation,
our annual report on Form 10-K for the fiscal year ended
December 31, 2012 and our quarterly
reports on Form 10-Q for the quarters ended March 31, 2013, June 30,
2013, and September 30, 2013.
We undertake no duty to update any forward-looking statement or any
information contained in this press release or in other public
disclosures at any time.
About Star Scientific
Star Scientific, Inc. is a technology-oriented company with a
mission to promote maintenance of a healthy metabolism and
lifestyle. Through its wholly owned subsidiary, Rock Creek
Pharmaceuticals, Star Scientific has been engaged in the
manufacturing, sale, and marketing of two nutraceutical dietary
supplements, cosmetic products, and the development of other
nutraceuticals and pharmaceuticals. The company also continues to
pursue the licensing of the technology behind its proprietary
StarCured® curing process and its related products.
Contact:
Talhia T. Tuck
Vice President, Communications and Investor Relations
Star Scientific, Inc.
(202)887-5100
ttuck@starscientific.com
SOURCE Star Scientific, Inc.